Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Is today not Wednesday? Jever?
FRIDAY!!!
NO WAIT!!!
THURSDAY!!!
So Zooluu..is the glass half empty or half full??
FROG....
SARASOTA, FL -- (MARKET WIRE) -- 04/20/06 --
DNAPrint Genomics, Inc. (DNAG - news) today announced that the Company has received a Notice of Allowance from the U.S. Patent and Tradmark Office for a patent application, Methods for the Identification of Genetic Features for Complex Genetics Classifiers. The patent protects the Company's methods for identifying links between gene sequences and phenotypes (physical or medical traits).
"Gene sequences are highly polymorphic in the population, which means that they come in various forms or 'flavors,'" stated DNAPrint Genomics Founder and Chief Scientific Officer Tony N. Frudakis. "Polymorphism is usually measured at the level of the single nucleotide polymorphism (SNP) but our technology measures at the level of the haplotype (strings of SNPs), which provides researchers considerably more information. The methods covered in the patent allow for an efficient and powerful means for identifying haplotype."
The recent patent provides legal protection for DNAPrint's status as one of a very few companies currently capable of performing objective, assumption-free haplotype analyses. DNAPrint is also the only company currently using Ancestry Informative Markers (AIMs) and has patents pending in this area as well. Because of limitations with traditional genome screening methods and the complex genetic characteristics of modern populations, AIMS are integral to the development of DNA tests for the inference of genetic ancestry based on phenotypes, including identifying certain physical characteristics, or an individual's predisposition to respond to certain drugs.
"The Company is committed to developing a new class of drugs, called 'theranostics,' which are test+drug combinations designed to help ensure that patients receive the appropriate medicine and proper dosage based on their genetic constitution. The application of theranostics is also designed to increase efficacy and reduce side-effects," said DNAPrint Chairman and Chief Medical Officer Hector J. Gomez, M.D., Ph.D. "Our sophisticated genetics technology is playing a key role in the research and development of potential new drugs."
"This patent cuts across a wide audience of developers from drug companies to people working on technology in the forensics and consumer areas," stated DNAPrint President and Chief Executive Officer Richard Gabriel. "We plan to vigorously utilize and practice our patents and we will be reviewing the fields of genetic testing, drug development, forensic sciences and consumer products with our patent counsel to determine potential areas of development. We want to ensure that we extract the greatest economic value out of this patent for our shareholders and investors."
DNAPrint Genomics currently holds two patents and has several others pending or in the hands of patent counsel
Google charges about $10,000 per month
bag8ger where did you find this newsletter?? It really knocked my socks off !!!
Michiko,
Rather that blaming the Company for selling shares look at the fact that someone has been consistantly selling below the bid price and the ask price to drop the SP. It seems to be an ongoing pattern evverytime the stock gains some momentum. Someone is obviously thriving on making money on tenths of cents rather than holding out for any real gains.
And the culprit looks like NITE.
JMHO
Jever000..somehow I don't believe that it was or is DNAG's intent to become fhe famous or infamous for the next "hot craze" sweeping the land. Kind of like the "Pet Rock", if you are old enough to remember that.
The ability to produce a breakthrough drug, rapid testing for genetic variations that predisposes one to adverse drug reactions, genetic testing for early detection of diseases and the like.
The development of these types of breakthroughs supercede any type of fast fading fad.
IMHO
Let's see some solid revenue producing, contract signing, drug production type of news and not the same ol' thing.
DNAG!!!! We need BIG NEWS and we need it soonnnn..
oh by the way Jeves when you run into Tony next time..ask him to update the website and write a shareholder letter more often.
jeves.. when does it end....
Time for DNAG to S..IT or get off the pot! As they say.. my loyalty to this stock after several years is beginning to wane..total frustration!!!!!!
Did anybody happen to catch the Wall Street Journal Today?? In the Money & Investing section article at the bottom of page C1
" Despite SEC Rules, a Small amount of Naked Shorting Appears to Persist"
to this I would have to say, "Upon further review, the SEC still has their Head, clearly up their poop chute" !!!!!!
jever000..my crystal balls are cracking we need more than "a little something" NOW!!!!
dorsey..you could get your.025 today
Jever000..although any press releases are a good thing we need NEWS THAT WILL KNOCK THE SOCKS OFF OF INVESTORS!!!
Like the introduction of the EPO to a big company that will start producing the product for market or the completion and sales of any of a number of other testing devices being developed.
OK Michiko...lay it on us
jever000..been there done that still waiting...done deals generally don't require a lot of time to hit the news wire!!
JEVER000...If the deal is done as you say...wheres the press release to support your claim??
jeves.. we know the SB2 was registered yesterday.
Jever..you are right again, the money is coming...DNAG just filed authorization to dutchess to release 600,000,000 new shares into the market when they see fit.
I don't think that this is the news we were looking for.
GCBR..I think the time is right to pursue the bashers. The constant barrage of unfounded "fact" they purport to have regarding this company amounts to no more cyber terrorism.
I for one have had enough.
I plan to contact the owners of this board and the proper authorities to isolate their IP addresses and pursue legal action. Enough is enough!!!
Yes there is a 1st amendment and right to free speech, however when free speech affects of the general public in a negative way and becomes a weapon to inflict economic damage with slander and libel. The 1st amendment goes out the window and the laywers immerge.
gcbr.....Sorry to say but I too own EAG
GCBR ...cool. Pin their sorry arses to the wall.
ala jever..HUGE NEWS NEXT WEEK!!!
TOMMORROW!!!! (just thought I would fill-in) for Jever. LOL
jever, your right I can't stand all of the excitement!!
DorseyE it looks like Tony applied for a patient for a test that would determine if a cancer patient would respond favorably to Taxol.
Apparently he developed a method in which treating oncologists could decide by using tony's gene markers test to use a different course of medication other than Taxol.
Shhhhh! Everybody's licking their wounds.
jeves..I'm relying on your batting average! The good doctor Fru has been suprisingly absent as of late, hopefully he bailed out for good reasons, meaning we are poised for better days ahead.
13 million shares traded...pps slides. I'm sure that selling shares into a down turn is not a way to raise market capitalization. It only serves to raise capital, the question is why and for what???
Even the market pinheads who short this stock have better things to do at this price!!!
A letter from Tony stating the current progress of products would be nice right about now!!!!!
A very painful day indeed...
Dorsey well for one it's demonstrating a shrinking gross margin since the cost of sales is eating into the sales. Also, the R&D expenses are growing as well as the cost of money borrowed.
We need higher revenues to cover these growing expenses in order to survive.
The short answer is we need BIG NEWS of a BIG project being completed. A focus by our company to get things done one at a time and get the result to market ASAP!!!!
A shotgun approach to projects does us no good. To many dollars in too many directions.
Yawn....
Jever000..Keep it in your pants, please!!!LOL
When is the 1st Qtr. 10QSB due out? We need a life raft!!!
dorsey, grat, xkem looks promising
Jeves...we need the 'Fast Track", "Super News" to launch us into the stratosphere.